ALDEYRA THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ALDEYRA THERAPEUTICS, INC. (ALDX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $7.50 million as of 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2022-03-17
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.50M.
- 2020-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $5.30M.
- 2019-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $8.10M.
- 2018-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.90M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2021-12-31 | $7.50M 10-K · filed 2022-03-17 |
| 2020-12-31 | $5.30M 10-K · filed 2021-03-11 |
| 2019-12-31 | $8.10M 10-K · filed 2020-03-12 |
| 2018-12-31 | $7.90M 10-K · filed 2019-03-08 |
| 2017-12-31 | $3.70M 10-K · filed 2018-03-29 |
| 2016-12-31 | $3.20M 10-K · filed 2017-03-30 |
| 2016-03-31 | $4.77M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $3.50M 10-K · filed 2016-03-30 |
| 2015-09-30 | $4.03M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $4.35M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $3.86M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $4.50M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |